Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms 18F-clofarabine, [18F]-CLOFARABINE |
Target |
Mechanism DCK inhibitors(Deoxycytidine kinase inhibitors), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Molecular FormulaC10H11ClFN5O3 |
InChIKeyWDDPHFBMKLOVOX-CZKFYJPXSA-N |
CAS Registry1134847-96-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Crohn Disease | Phase 1 | US | 25 Jan 2016 | |
Inflammation | Phase 1 | US | 25 Jan 2016 | |
Rheumatoid Arthritis | Phase 1 | US | 25 Jan 2016 | |
Systemic Lupus Erythematosus | Phase 1 | US | 25 Jan 2016 | |
Takayasu Arteritis | Phase 1 | US | 25 Jan 2016 |